Annotation Detail

Information
Associated Genes
PIK3CA
Associated Variants
PIK3CA MUTATION
PIK3CA MUTATION
Associated Disease
stomach cancer
Source Database
CIViC Evidence
Description
In a panel of 22 gastric cancer cell lines, 4 of 6 cell lines having the highest sensitivity to AZD5363 contained a PIK3CA mutation (E542K, E453K, E545K). A patient derived gastric cancer xenograft mouse model was established with PIK3CA H1047R mutant cells, and treatment with AZD5363 induced significant tumor growth inhibition in comparison to vehicle control.
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1501
Gene URL
https://civic.genome.wustl.edu/links/genes/37
Variant URL
https://civic.genome.wustl.edu/links/variants/311
Rating
3
Evidence Type
Predictive
Disease
Stomach Cancer
Evidence Direction
Supports
Drug
Capivasertib
Evidence Level
D
Clinical Significance
Sensitivity/Response
Pubmed
24088382
Drugs
Drug NameSensitivitySupported
CapivasertibSensitivitytrue